Alzamend Neuro's total assets for Q2 2026 were $5.09M, a decrease of -19.52% from the previous quarter. ALZN total liabilities were $717.49K for the fiscal quarter, a -27.03% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.